Late results (>10 years) of intracoronary beta brachytherapy for diffuse in-stent restenosis
Introduction: Until the development of drug-eluting stents (DES), diffuse in-stent restenosis (ISR) was the main limitation of bare-metal stents in percutaneous coronary intervention (PCI). Among the different treatments available, intracoronary brachytherapy (BT) emerged as one of the most promisin...
Main Authors: | Ricardo Seabra Gomes, Pedro de Araújo Gonçalves, Rui Campante Teles, Manuel de Sousa Almeida |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-10-01
|
Series: | Revista Portuguesa de Cardiologia (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2174204914002025 |
Similar Items
-
Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01) -
Intracoronary brachytherapy in the treatment of in-stent restenosis. Initial experience in Brazil
by: Fábio Sândoli de Brito Jr, et al.
Published: (2001-09-01) -
Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01) -
Intracoronary radiation for in-stent restenosis
by: Malenkianpoor Mehrdad, et al.
Published: (2000-09-01) -
Usefulness of intracoronary imaging techniques in the percutaneous treatment of in-stent restenosis
by: Juan Ruiz-García, et al.
Published: (2013-12-01)